Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ApconiX is an expert consultancy and laboratory specializing in nonclinical toxicology, DMPK, ion channel biology, cardiac/CNS electrophysiology, and target safety assessments. It provides flexible support to pharma/biotech companies globally for discovery through development projects. The company has developed proprietary assays such as iSLA® for CNS seizure liability screening and Acuity® for customized target safety assessments. ApconiX has supported successful regulatory submissions enabling clinical trial authorizations for client assets[1][6].
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on ApconiX.